These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29146290)

  • 1. Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.
    Wang AL; Lowen SB; Elman I; Shi Z; Fairchild VP; Bouril A; Gur RC; Langleben DD
    J Subst Abuse Treat; 2018 Feb; 85():70-77. PubMed ID: 29146290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baby schema modulates the brain reward system in nulliparous women.
    Glocker ML; Langleben DD; Ruparel K; Loughead JW; Valdez JN; Griffin MD; Sachser N; Gur RC
    Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9115-9. PubMed ID: 19451625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.
    Wang AL; Elman I; Lowen SB; Blady SJ; Lynch KG; Hyatt JM; O'Brien CP; Langleben DD
    Transl Psychiatry; 2015 Mar; 5(3):e531. PubMed ID: 25781230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.
    Shi Z; Wang AL; Jagannathan K; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    J Psychiatry Neurosci; 2018 Jul; 43(4):254-261. PubMed ID: 29947607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baby Schema in Infant Faces Induces Cuteness Perception and Motivation for Caretaking in Adults.
    Glocker ML; Langleben DD; Ruparel K; Loughead JW; Gur RC; Sachser N
    Ethology; 2009 Mar; 115(3):257-263. PubMed ID: 22267884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.
    Langleben DD; Ruparel K; Elman I; Loughead JW; Busch EL; Cornish J; Lynch KG; Nuwayser ES; Childress AR; O'Brien CP
    Addict Biol; 2014 Mar; 19(2):262-71. PubMed ID: 22747521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and Accumbal Responses During an Affective Go/No-Go Task Predict Adherence to Injectable Naltrexone Treatment in Opioid Use Disorder.
    Shi Z; Jagannathan K; Wang AL; Fairchild VP; Lynch KG; Suh JJ; Childress AR; Langleben DD
    Int J Neuropsychopharmacol; 2019 Mar; 22(3):180-185. PubMed ID: 30690502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).
    Kunøe N; Opheim A; Solli KK; Gaulen Z; Sharma-Haase K; Latif ZE; Tanum L
    BMC Pharmacol Toxicol; 2016 Apr; 17(1):18. PubMed ID: 27121539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
    Kohno M; Dennis LE; McCready H; Schwartz DL; Hoffman WF; Korthuis PT
    Drug Alcohol Depend; 2018 Nov; 192():186-192. PubMed ID: 30266003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence.
    Earley PH; Zummo J; Memisoglu A; Silverman BL; Gastfriend DR
    J Addict Med; 2017; 11(3):224-230. PubMed ID: 28358754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What a cute baby! Preliminary evidence from a fMRI study for the association between mothers' neural responses to infant faces and activation of the parental care system.
    Endendijk JJ; Smit AK; van Baar AL; Bos PA
    Neuropsychologia; 2020 Jun; 143():107493. PubMed ID: 32407904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
    Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Boney TY; Hoskinson RA; Wilson D; McDonald R; Rotrosen J; Gourevitch MN; Gordon M; Fishman M; Chen DT; Bonnie RJ; Cornish JW; Murphy SM; O'Brien CP
    N Engl J Med; 2016 Mar; 374(13):1232-42. PubMed ID: 27028913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in naltrexone implant treatment for opioid dependence.
    Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen O; Waal H
    Drug Alcohol Depend; 2010 Sep; 111(1-2):166-9. PubMed ID: 20570059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].
    Krupitskiĭ EM; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Blokhina EA; Silverman BL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):3-11. PubMed ID: 22951790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone: Not Just for Opioids Anymore.
    Sudakin D
    J Med Toxicol; 2016 Mar; 12(1):71-5. PubMed ID: 26546222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
    Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence.
    Langleben DD; Busch EL; O'Brien CP; Elman I
    Psychopharmacology (Berl); 2012 Apr; 220(3):559-64. PubMed ID: 21960180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
    Bisaga A; Mannelli P; Yu M; Nangia N; Graham CE; Tompkins DA; Kosten TR; Akerman SC; Silverman BL; Sullivan MA
    Drug Alcohol Depend; 2018 Jun; 187():171-178. PubMed ID: 29674251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe opioid withdrawal precipitated by Vivitrol®.
    Wightman RS; Nelson LS; Lee JD; Fox LM; Smith SW
    Am J Emerg Med; 2018 Jun; 36(6):1128.e1-1128.e2. PubMed ID: 29605483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reward value of infant facial cuteness tracks within-subject changes in women's salivary testosterone.
    Hahn AC; DeBruine LM; Fisher CI; Jones BC
    Horm Behav; 2015 Jan; 67():54-9. PubMed ID: 25481544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.